We help healthcare organisations to build and maintain successful and sustainable business.
Together with our two specialised consultancies, Bazian and Clearstate, EIU Healthcare provides customised research, analysis and recommendations across the healthcare ecosystem.
Current highlights
IVD Gateway
To develop a good sales and marketing strategy, you need to know the value and volume of the business you can capture. Clearstate, an EIU Healthcare business, has developed a comprehensive In Vitro Diagnostics (IVD) database which delivers precise data and forecasts for each of the major IVD segments in Asia-Pacific and Latin America.
Learn moreSouth-East Asia: The New Emerging Healthcare Market Challenge
Report by Clearstate
Over the next 5 years, healthcare markets in South-East Asia like Indonesia and Philippines will exceed growth in BRIC healthcare markets. Our latest whitepaper offers a market-by- market outlook for all 10 countries in South-East Asia from 2016-2020, and identifies 5 mega-trends shaping South-East Asia’s healthcare landscape to help pharmas and medtechs capitalise on these emerging trends.
Download free reportSubscribe to EIU Healthcare newsletter
Our two specialised consultancies, Bazian and Clearstate, provide you with the latest research, analysis and recommendations from across the healthcare ecosystem.
SubscribeOur services
EIU Healthcare is a global healthcare practice that brings together two specialised consultancies, Bazian and Clearstate, with EIU’s outstanding and world renowned analytical, econometric & strategic advisory services, to provide you with healthcare intelligence that is second to none.
- Insurer & payor solutions
- Value consulting
- Market insight & intelligence
- Strategic advisory
Insurer & payor solutions
Helping payors, insurers and their partners to build healthcare ecosystems that optimise value.
We can research and provide:
- Care pathways and protocols
- Clinical and public health guidelines
- Rapid evidence reviews
- Systematic reviews and health technology assessments
- Demand and capacity forecasts
- Clinical quality metrics
- Public health and clinical analytics
- Consulting on how to set up systems for population health management and value-based health
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Value consulting
Helping pharmas and medtechs to develop propositions, products and services in a market where value is the emerging currency.
We can research and provide:
- Value optimisation
- Value consulting
- R&D portfolio assessment
- Market access solutions
- Evidence reviews
- Systematic reviews
- Clinical pathway analysis
- Health economic modelling
- Competitive value analysis
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Market insight & intelligence
Harness the global expertise of The EIU’s Healthcare Briefing service, alongside the unique focus on emerging markets provided by Clearstate, to gain deep dive insight that will guide your next investment.
We can research and provide:
- Market intelligence
- Market sizing
- Channel optimisation
- Market access
- Commercial due diligence
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Strategic advisory
Utilising the unique resources of The EIU databases, we can identify global and local trends, and map them against your business priorities to ensure a robust and future-proof market strategy.
We can research and provide:
- Horizon scan and environmental scan
- Megatrend analysis
- Country analysis
- Industry analysis
- Prioritising and identifying opportunity
- Senior facilitation and speaker services
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
How we can help
Whether you’re looking to grow in an emerging market or to optimise your established business we can engage with you and assist at every stage of your planning.
You are:
Developing new products and services to address the unmet needs of emerging economies and value based health.
We can:
- Test new concepts
- Explore localisation
- Discover upcoming user trends
- Measure value in your pipelines
Why choose us
EIU Healthcare has a thorough understanding of the healthcare ecosystem. Our healthcare analysts all have deep insight into the healthcare system. We speak the industry language and are respected professionals who share with you a common purpose - to provide high quality, affordable, commercially viable and future-proofed healthcare, globally.
Clients
We are trusted by a growing base of clients in pharma, medtech and healthcare services.
Market insight & intelligence
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_01.png)
The Economist Intelligence Unit has developed a detailed macroeconomic model factoring inter alia, province-level income breakdowns, personal wealth, government policies and the insurance landscape. The model includes long-term (>20 year) forecasts. Leveraging our proprietary data and macroeconomic forecasting capabilities, we have been able to offer robust analysis of the demand for specific therapies at a subnational level within emerging markets. Our models are dynamic, designed for internal strategic use and can be directly integrated with the clients’ own forecasting models, allowing mapping of affordability levels to drug prices, reimbursement rates, incomes and disease epidemiology.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Insurer & payor solutions
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_02.png)
Novo Nordisk asked The Economist Intelligence Unit to calculate the economic cost of diabetes worldwide. The client wanted us to quantify the economic burden of disease in specific emerging and developed countries in order to fully understand the scale of the problem. Our in-house team of country analysts and skilled macroeconomists developed methodologically solid estimates and forecasts across a variety of markets. We developed a model estimating direct healthcare and non-healthcare related costs, as well as the impact of the illness on economic productivity. The results were incorporated in a white paper outlining the major challenges and opportunities in addressing the problem. This was released on the web for public consumption, and benefited from The Economist Intelligence Unit's editorial trademark.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Strategic advisory
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_03.png)
Our client lacked existing products to access China’s fast-growing primary care and home healthcare segments. It asked us to undertake high-level discussions with government policymakers and advisory boards on development directions. We conducted in-depth concept tests with decision-makers and clinicians on product attractiveness and viability, as well as trade-off analysis to gauge the importance of price versus features. This enabled our client to gain insights on government initiatives that will affect product development, allowing it to adapt product design to local demand and to launch its product at the most effective price point and positioning.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Value consulting
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_04.png)
Our client, a leading pharmaceutical company with a portfolio of drugs in chronic pain management, wanted us to review regulatory regimes governing how the cost of sick leave is shared in 17 European countries and to provide an assessment of quantitative information on the cost of chronic pain. We undertook a review of regulatory systems of the countries in scope and developed a data visualisation tool for the client to understand how the burden of sick leave is shared between the state, the employer and the employee. Our data provided insights on relative market opportunity for the strategic planning team, and enabled it to engage stakeholders and payers in productivity and healthcare conversations.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Market insight & intelligence
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_05.png)
The World Bank wanted to stimulate debate around public-private interactions in Sub-Saharan African healthcare systems, to generate policy reform and attention, ultimately seeking to boost healthcare investment levels and efficacy in the region. We prepared data visualisation and comparisons for report country pages and liaised with journalists at The Economist to help to make the report more accessible to policymakers and the general public. The final product was a series of externally facing co-branded research and white papers, created to facilitate thought leadership and debate.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Insurer & payor solutions
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_06.png)
Our client wanted to evaluate the cost of providing vaccines to Sub-Saharan African countries. They also wanted to map the findings to the predicted domestic government contributions to financing the cost of these vaccines and to forecast the cost-funding gap from 2009-20. We leveraged our Africa team’s country economic and forecasting expertise to produce country-specific healthcare budget forecasts. Our in-house modelling expertise, partnered with key academic institutions, enabled us to prepare vaccine cost forecasts. Finally, we drew upon our data visualisation skill to house the data in a user-friendly spreadsheet model with country-specific drop-down menus and tabs showing different data aspects, which enabled the client to use the output for fundraising and planning purposes.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Strategic advisory
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_07.png)
We have worked for a number of pharma and medtech clients to identify the key innovations in the healthcare sector and evaluate opportunities for greenfield investment and future business expansion. We design global studies, provide recommendations and moderate workshops and brainstorming sessions at a Board level. We analyse resulting themes and their impact/implications, and can present our findings to the board if required.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Value consulting
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_08.png)
Payors like the NHS are increasingly demanding healthcare solutions rather than product offerings. This study illustrates work that we can do with suppliers to help them engage constructively with payors. Our client needed to understand the market potential, demand and case mix for renal replacement therapy and how it will evolve in the next five years. We developed an interactive demand and capacity model that informed our client’s planning process, factoring macro considerations such as disease prevalence rates, demographic changes and patient flows. The client uses the interactive model to plan capacity and to assess the potential impact of service configuration changes to the flow of patients, as well as to allocate budget.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Market insight & intelligence
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_09.png)
Our client needed to develop deep customer insights to tap into upcoming opportunities in the new and low-volume workload segments in China and India in the next five years. We conducted in-depth interviews with opinion leaders to gauge views of demand dynamics and technology movements, and produced an activity-based gap analysis of a representative sample size of mid- to low-workload lab users to identify penetration and adoption opportunities. From this, we identified gaps that can potentially be converted into opportunities through activity-based analysis and advised on new trends that can shape demand.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Insurer & payor solutions
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_10.png)
BUPA recognised clinically unwarranted variation in the number of claims around knee arthroscopy procedures among its provider network. It needed to manage the variation in practice in a way that was clinically robust. We examined the evidence on effectiveness of the procedure in different patient groups. We then constructed a robust analysis, stratified by patient group and specific clinical criteria. From this, the client designed pre-authorisation processes and tools, and developed patient communications to assist with shared decision-making and informed choices. This has helped BUPA to standardise care and optimise value by eliminating clinically inappropriate claims. The broader effect is that the providers now know that the payer is performance managing from a clinical perspective, resulting in fewer claims and clinically appropriate use of the technique.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Strategic advisory
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_11.png)
We conducted extensive research into a variety of innovative care models from around the world. At a workshop session, which brought together payers and providers, we examined these models and facilitated the development of implementation plans for models that were regarded as attractive. As a follow up to the project, we engaged on a one-to-one basis with the senior management of a number of participating providers, to examine and advise on key strategic issues, drawing on our sector expertise and research capabilities.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Value consulting
![](/web/20170118150759im_/http://www.eiu.com/images/healthcare/clients/Big_image_12.png)
Our client lacked existing products to access China’s fast-growing primary care and home healthcare segments. It asked us to undertake high-level discussions with government policymakers and advisory boards on development directions. We conducted in-depth concept tests with decision-makers and clinicians on product attractiveness and viability, as well as trade-off analysis to gauge the importance of price versus features. This enabled our client to gain insights on government initiatives that will affect product development, allowing it to adapt product design to local demand and to launch its product at the most effective price point and positioning.
![go back](/web/20170118150759im_/http://www.eiu.com/images/common/flip_arrow.png)
Thinking and events
We are trusted by a growing base of clients in pharma, medtech and healthcare services.
White papers
Latest tweets
About us
The EIU has 380 full-time and contributing analysts worldwide including 60 dedicated healthcare specialists.
The healthcare team incorporates two leading healthcare research companies, Bazian and Clearstate.
Bazian specialises in evidence-based analysis of drugs, devices and healthcare services. Using internationally recognised scientific and statistical methods, it establishes the clinical outcomes and value for money proposition offered.
Clearstate helps firms better understand the current and potential markets for their business. Clearstate’s team of researchers recommends solutions for clients through analysis of hard-to-gather facts, and a systematic and seasoned understanding of markets.
![map of the location of our healthcare analysts](/web/20170118150759im_/http://www.eiu.com/images/healthcare/map.png)